Testing a focus medication for children with sickle cell disease

This trial is testing whether methylphenidate, a medication commonly used to improve attention and focus, can help children with sickle cell disease who struggle with executive functioning—skills like paying attention, remembering things, and controlling impulses. Kids in this study will take the medication once a day for 4 weeks while doctors carefully watch for any side effects and measure whether the treatment helps with focus and school performance.

Children with sickle cell disease are more likely to have trouble with attention and executive functioning, which can hurt their grades, quality of life, and ability to manage their health as they grow up. Even though this medication works well for attention problems in other groups of kids, it's rarely been tested safely in children with sickle cell disease.